U.S. Professional Services Stock News

NasdaqGS:SKWD
NasdaqGS:SKWDInsurance

Skyward Specialty Insurance Group (SKWD) Stock Could Be 20.5% Undervalued After Apollo Acquisition

Skyward Specialty Insurance Group (SKWD) is drawing fresh attention after acquiring Apollo Group Holdings, a move that broadens its specialty insurance offerings and sharpens its focus on niche, underserved commercial markets. See our latest analysis for Skyward Specialty Insurance Group. Skyward Specialty Insurance Group’s recent Apollo deal comes on the back of firm price momentum, with a 90 day share price return of 21.95% and a 30 day share price return of 5.56%. However, the 1 year total...
NYSE:JOBY
NYSE:JOBYAirlines

Joby Aviation (JOBY) Stock Could Be 23% Undervalued After FAA Progress And Production Plans

Joby Aviation (JOBY) is back in focus after reaching stage four of the FAA’s type certification process, supported by new survey data showing strong consumer interest in eVTOL flights and expanding production plans in Dayton. See our latest analysis for Joby Aviation. Recent milestones appear to have renewed interest in Joby Aviation, with the stock showing a 6.22% total shareholder return over the past year, even as the year to date share price return is down 34.61% from earlier levels. If...
NasdaqGS:LITE
NasdaqGS:LITECommunications

Lumentum Holdings (LITE) Stock Could Be 82.9% Undervalued If Turnaround Hopes Hold

Lumentum Holdings (LITE) has recently drawn investor attention after a period where the stock is up about 1.9% over the past week but down roughly 1.7% over the past month. See our latest analysis for Lumentum Holdings. Zooming out, Lumentum Holdings’ recent 7 day share price gain sits against a 90 day share price return of 12.67% and a very large 1 year total shareholder return. This suggests that momentum has been building over time as investors reassess its growth prospects and risk...
NasdaqGS:ALHC
NasdaqGS:ALHCHealthcare

How Investors May Respond To Alignment Healthcare (ALHC) Earnings Beat And Leadership Reshuffle

Earlier this quarter, Alignment Healthcare reported first-quarter 2026 results that exceeded analyst expectations on both earnings and revenue, alongside announcing a leadership restructuring that elevated CEO John Kao to Chairman and shifted Joseph Konowiecki to Vice Chairman and Executive Vice President of Corporate Affairs. At the same time, the company’s shift from losses to positive earnings, improving free cash flow margins, and strong financial efficiency scores highlight a business...
NYSE:ALL
NYSE:ALLInsurance

How Investors Are Reacting To Allstate (ALL) Halting Monthly Auto Policy Updates Amid Digital Shift

Earlier this week, Keefe Bruyette downgraded The Allstate Corporation to “Market Perform,” pointing to evidence that previously accelerating growth in personal auto policies in force likely peaked in February and highlighting the company’s move to halt monthly reporting of these metrics after May in favor of quarterly disclosure. This shift away from monthly policy reporting reduces near‑term visibility into Allstate’s core auto franchise, potentially sharpening investor focus on how the...
NasdaqGS:FCNC.A
NasdaqGS:FCNC.ABanks

Will Flat Q1 Revenue And Missed NII Estimates Change First Citizens BancShares' (FCNC.A) Narrative

In the recent Q1 results, First Citizens BancShares reported flat revenue compared with a year earlier and fell short of analysts’ net interest income and total revenue estimates. This weaker-than-anticipated quarter raises questions about how effectively the bank’s lending and deposit franchises are translating into top-line growth and interest income resilience. We’ll now examine how this flat revenue performance and missed net interest income estimates may affect First Citizens...
NYSE:JOE
NYSE:JOEReal Estate

St. Joe (JOE) Stock Could Be 48% Below Fair Value Despite A Rich P/E

St. Joe (JOE) is back on investors’ radar after recent share price moves. This has prompted a closer look at how the real estate-focused company’s mix of residential, hospitality, and commercial operations supports its current valuation. See our latest analysis for St. Joe. At a recent share price of US$63.48, St. Joe’s short term share price performance has softened, with the 90 day share price return down 7.73%, even as the 1 year total shareholder return stands at 36.90% and the 5 year...
NYSE:AMH
NYSE:AMHResidential REITs

American Homes 4 Rent (AMH) Stock Could Be 9.8% Undervalued After Recent Rebound

American Homes 4 Rent (AMH) has drawn investor attention after recent trading left the stock around its reported intrinsic discount of 33%, with shares closing at US$31.83 and a market value near US$13.3b. See our latest analysis for American Homes 4 Rent. Over the past quarter, American Homes 4 Rent’s share price return of 13.11% contrasts with a decline of 9.28% in the 1 year total shareholder return. This suggests recent momentum has picked up after a weaker period despite the current...
NYSE:AIR
NYSE:AIRAerospace & Defense

Why AAR (AIR) Is Up 12.6% After Surging Revenue and Sold-Out New MRO Capacity

AAR recently reported a past quarter in which revenue rose 25.3% year on year, beating analysts’ estimates for both revenue and adjusted operating income, as management pointed to robust momentum across the business including 14% organic adjusted sales growth. At the same time, AAR has been expanding its Maintenance, Repair, and Overhaul footprint with fully booked hangar additions in Oklahoma City and Miami, while institutional ownership has climbed to very high levels, underscoring rising...
NYSE:SMWB
NYSE:SMWBSoftware

3 Promising Penny Stocks With At Least $200M Market Cap

Over the last 7 days, the United States market has risen by 2.0%, and over the past 12 months, it is up by 23%, with earnings expected to grow significantly in the coming years. For those looking to invest in smaller or newer companies, penny stocks—despite being an older term—can still offer surprising value when they are built on solid financial foundations. In this article, we explore several penny stocks that demonstrate financial strength and potential for long-term growth, offering...
NasdaqGS:ASML
NasdaqGS:ASMLSemiconductor

ASML Holding (NasdaqGS:ASML) Stock Looks Fully Priced After Strong Recent Gains

ASML Holding (NasdaqGS:ASML) stock has recently drawn attention after a series of strong trailing returns, with the shares up 3.5% in the past day and 7.7% over the past week. See our latest analysis for ASML Holding. At a share price of $1,867.83, ASML Holding sits on strong recent momentum, with a 30 day share price return of 26.86% and a 1 year total shareholder return of 146.87%. This suggests investors have recently been willing to pay more for its earnings and growth profile. If you are...
NYSE:CTVA
NYSE:CTVAChemicals

What Corteva (CTVA)'s Rimisoxafen Deal With FMC Means For Shareholders

Earlier this week, FMC Corporation and Corteva, Inc. announced a co-exclusive supply and license agreement giving Corteva access to FMC’s rimisoxafen herbicide technology for corn and soybean markets across North and South America, including an initial US$200,000,000 prepurchase commitment. This agreement broadens Corteva’s weed-control toolkit with a differentiated active ingredient targeting resistant species, potentially reinforcing its crop protection franchise alongside ongoing...
NasdaqGS:XRAY
NasdaqGS:XRAYMedical Equipment

DENTSPLY SIRONA (XRAY) Stock Could Be 78% Undervalued After CFO Appointment

DENTSPLY SIRONA (XRAY) is back in focus after the company appointed John C. Fortson as Chief Financial Officer and Executive Vice President, a leadership change that could influence how investors view the stock. See our latest analysis for DENTSPLY SIRONA. The latest leadership news arrives after a tough stretch for DENTSPLY SIRONA. The share price is down 11% year to date and the 1 year total shareholder return has fallen 32.4%, pointing to fading momentum despite a modest 2.1% 1 month share...
NYSE:HTGC
NYSE:HTGCCapital Markets

Does Dyne Loan Expansion Amid Lawsuit Change The Bull Case For Hercules Capital (HTGC)?

In recent weeks, Hercules Capital has faced an investor lawsuit alleging overstated due diligence and portfolio valuations, even as it amended a senior secured term loan facility with Dyne Therapeutics to provide up to US$125.00 million in additional borrowing capacity. This combination of legal scrutiny and expanded lending activity highlights the tension between questions over past disclosures and the company’s ongoing role as a key non-bank lender to high-growth sectors. Against this...